{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ACAD/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T16:05:31.922Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9305,"canonical_name":"ACADIA PHARMACEUTICALS INC","cik":"0001070494","uei":null,"lei":null,"duns":null,"ticker":"ACAD"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":46},"count":46,"timeline":[{"ts":"2026-09-24","kind":"sec.filing","form_type":"8-K","title":"8-K — ACADIA PHARMACEUTICALS INC — 2026-09-24","url_slug":"/sec/cik-0001070494/8-k/0001193125-26-401157","accession_number":"0001193125-26-401157","importance":35},{"ts":"2026-09-11","kind":"sec.filing","form_type":"8-K","title":"8-K — ACADIA PHARMACEUTICALS INC — 2026-09-11","url_slug":"/sec/cik-0001070494/8-k/0001193125-26-389400","accession_number":"0001193125-26-389400","importance":35},{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — ACADIA PHARMACEUTICALS INC — 2026-08-07","url_slug":"/sec/cik-0001070494/schedule-13g/0000093751-26-000400","accession_number":"0000093751-26-000400","importance":55},{"ts":"2026-08-07","kind":"sec.filing","form_type":"4","title":"4 — ACADIA PHARMACEUTICALS INC — 2026-08-07","url_slug":"/sec/cik-0001070494/4/0001899977-26-000008","accession_number":"0001899977-26-000008","importance":30},{"ts":"2026-08-06","kind":"sec.insider.s","reporter":"Schneyer Mark C.","title":"EVP, CHIEF FINANCIAL OFFICER","shares":9292,"price_per_share":29.3375,"usd_value":272604,"security_title":"Common Stock","importance":35.27260405},{"ts":"2026-08-06","kind":"sec.insider.s","reporter":"Schneyer Mark C.","title":"EVP, CHIEF FINANCIAL OFFICER","shares":5000,"price_per_share":29,"usd_value":145000,"security_title":"Common Stock","importance":35.145},{"ts":"2026-08-06","kind":"sec.insider.m","reporter":"Schneyer Mark C.","title":"EVP, CHIEF FINANCIAL OFFICER","shares":14292,"price_per_share":17.84,"usd_value":254969,"security_title":"Common Stock","importance":15.25496928},{"ts":"2026-08-05","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ACADIA PHARMACEUTICALS INC — 2026-08-05","url_slug":"/sec/cik-0001070494/10-q/0001193125-26-333243","accession_number":"0001193125-26-333243","importance":45},{"ts":"2026-08-05","kind":"sec.insider.s","reporter":"Schneyer Mark C.","title":"EVP, CHIEF FINANCIAL OFFICER","shares":5849,"price_per_share":29.0029,"usd_value":169638,"security_title":"Common Stock","importance":35.1696379621},{"ts":"2026-08-05","kind":"sec.filing","form_type":"144","title":"144 — ACADIA PHARMACEUTICALS INC — 2026-08-05","url_slug":"/sec/cik-0001070494/144/0001967940-26-000042","accession_number":"0001967940-26-000042","importance":30},{"ts":"2026-08-05","kind":"sec.insider.m","reporter":"Schneyer Mark C.","title":"EVP, CHIEF FINANCIAL OFFICER","shares":5849,"price_per_share":17.84,"usd_value":104346,"security_title":"Common Stock","importance":15.10434616},{"ts":"2026-08-04","kind":"sec.filing","form_type":"8-K","title":"8-K — ACADIA PHARMACEUTICALS INC — 2026-08-04","url_slug":"/sec/cik-0001070494/8-k/0001193125-26-332858","accession_number":"0001193125-26-332858","importance":35},{"ts":"2026-07-31","kind":"sec.filing","form_type":"4","title":"4 — ACADIA PHARMACEUTICALS INC — 2026-07-31","url_slug":"/sec/cik-0001070494/4/0001861477-26-000005","accession_number":"0001861477-26-000005","importance":30},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Thompson Elizabeth H.Z.","title":"EVP, Head of Research & Dev","shares":16508,"price_per_share":26.13,"usd_value":431354,"security_title":"Common Stock","importance":35.43135404},{"ts":"2026-07-30","kind":"sec.insider.s","reporter":"Thompson Elizabeth H.Z.","title":"EVP, Head of Research & Dev","shares":50,"price_per_share":26.17,"usd_value":1309,"security_title":"Common Stock","importance":35.0013085},{"ts":"2026-07-29","kind":"sec.insider.m","reporter":"Thompson Elizabeth H.Z.","title":"EVP, Head of Research & Dev","shares":32272,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-29","kind":"sec.filing","form_type":"4","title":"4 — ACADIA PHARMACEUTICALS INC — 2026-06-29","url_slug":"/sec/cik-0001070494/4/0001816160-26-000009","accession_number":"0001816160-26-000009","importance":30},{"ts":"2026-06-26","kind":"sec.form144","reporter":"Kihara James","title":"Officer","shares":11421,"usd_value":297000,"security_title":"Common Stock","approx_sale_date":"2026-06-26","accession_number":"0001967940-26-000036","importance":40.0594},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Kihara James","title":"PRINCIPAL ACCOUNTING OFFICER","shares":11421,"price_per_share":26.0846,"usd_value":297912,"security_title":"Common Stock","importance":35.2979122166},{"ts":"2026-06-26","kind":"sec.filing","form_type":"144","title":"144 — ACADIA PHARMACEUTICALS INC — 2026-06-26","url_slug":"/sec/cik-0001070494/144/0001967940-26-000036","accession_number":"0001967940-26-000036","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"S-8","title":"S-8 — ACADIA PHARMACEUTICALS INC — 2026-06-10","url_slug":"/sec/cik-0001070494/s-8/0001193125-26-265809","accession_number":"0001193125-26-265809","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — ACADIA PHARMACEUTICALS INC — 2026-06-02","url_slug":"/sec/cik-0001070494/4/0001193125-26-253632","accession_number":"0001193125-26-253632","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — ACADIA PHARMACEUTICALS INC — 2026-06-01","url_slug":"/sec/cik-0001070494/4/0001177917-26-000009","accession_number":"0001177917-26-000009","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — ACADIA PHARMACEUTICALS INC — 2026-06-01","url_slug":"/sec/cik-0001070494/4/0001365619-26-000002","accession_number":"0001365619-26-000002","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — ACADIA PHARMACEUTICALS INC — 2026-06-01","url_slug":"/sec/cik-0001070494/4/0001560782-26-000002","accession_number":"0001560782-26-000002","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — ACADIA PHARMACEUTICALS INC — 2026-06-01","url_slug":"/sec/cik-0001070494/4/0001604689-26-000009","accession_number":"0001604689-26-000009","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — ACADIA PHARMACEUTICALS INC — 2026-06-01","url_slug":"/sec/cik-0001070494/4/0001826361-26-000002","accession_number":"0001826361-26-000002","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — ACADIA PHARMACEUTICALS INC — 2026-06-01","url_slug":"/sec/cik-0001070494/4/0001865210-26-000002","accession_number":"0001865210-26-000002","importance":30},{"ts":"2026-05-29","kind":"sec.insider.m","reporter":"HARRIGAN EDMUND","title":"","shares":8107,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.m","reporter":"Daly James M","title":"","shares":8107,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.m","reporter":"Brege Laura","title":"","shares":8107,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.m","reporter":"Poole Jonathan","title":"","shares":2010,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.m","reporter":"GAROFALO ELIZABETH A.","title":"","shares":8107,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.m","reporter":"Ndu Adora","title":"","shares":8107,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"BAKER BROS. ADVISORS LP","title":null,"shares":18622,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"667, L.P.","title":null,"shares":18622,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Baker Bros. Advisors (GP) LLC","title":null,"shares":18622,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Baker Brothers Life Sciences LP","title":null,"shares":18622,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"BAKER FELIX","title":null,"shares":18622,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"BAKER JULIAN","title":null,"shares":18622,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"BAKER BROS. ADVISORS LP","title":null,"shares":18622,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"667, L.P.","title":null,"shares":18622,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Baker Bros. Advisors (GP) LLC","title":null,"shares":18622,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Baker Brothers Life Sciences LP","title":null,"shares":18622,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"BAKER FELIX","title":null,"shares":18622,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"BAKER JULIAN","title":null,"shares":18622,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15}]}